EUVIMEDEUVIMED entdecken
Multizentrische Studie

Treatment Patterns and Outcomes in Localized Urothelial Carcinoma in Middle-Income Countries: A Multicenter Real-World Study

André Paternò Castello Dias Carneiro, Elice Carneiro Batista iD, Diogo Diniz Gomes Bugano iD, Rodrigo Guimarães Corradi iD, Renato Panhoca iD, João Antonio Soler iD, Eduardo Carvalhal, Andréa Lopes Ponte de Souza iD, Bruna Motke iD, Henrique Alkalay Helber iD, Bruna Dos Santos Sampaio iD, Frederico Monfardini iD und 12 weitere

JCO Global Oncology · 2026-04 · 12 (4)

DOI: 10.1200/go-25-00324 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JCO Global Oncology, 2026-04. Verfasst von André Paternò Castello Dias Carneiro und 23 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Israelita Albert Einstein, São Paulo, Brazil. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Carcinoma, Transitional Cell. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Disparities in health care access and resource availability in middle-income countries often lead to suboptimal management of localized bladder urothelial carcinoma (UC). However, real-world data describing treatment patterns and outcomes in these settings remain limited. METHODS This multicenter, retrospective, real-world study included patients with high-risk non–muscle-invasive (HR-NMIBC) and localized muscle-invasive bladder cancer (MIBC) diagnosed between 2017 and 2022 across nine cancer centers in a middle-income setting. Treatment data and clinical outcomes were collected from medical records and analyzed using descriptive statistics and Kaplan-Meier survival estimates. RESULTS Among 343 patients analyzed, 217 (63.3%) had HR-NMIBC, of whom only 29.5% received adjuvant Bacillus Calmette-Guérin (BCG), often substituted with intravesical gemcitabine because of supply shortages. BCG exposure was associated with superior overall and cancer-specific survival compared with non-BCG patients. In the muscle-invasive cohort (n = 126; 36.7%), cystectomy was performed in 48.4% and significantly improved survival. Perioperative chemotherapy remained limited, with only 39.3% receiving neoadjuvant therapy, and just one third receiving cisplatin-based regimens that conferred the greatest survival benefit. CONCLUSION This multicenter real-world study exposes major gaps in the management of localized UC in a middle-income setting. Limited access to BCG, perioperative chemotherapy, and cystectomy remain key barriers to guideline-concordant care, underscoring the urgent need for policy actions to improve treatment delivery and outcomes in comparable health care systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCarcinoma, Transitional CellHumansFemaleRetrospective StudiesMaleTreatment OutcomeAgedBCG VaccineNon-Muscle Invasive Bladder NeoplasmsMiddle AgedCystectomyGemcitabineDeoxycytidine

Substanzen

BCG VaccineGemcitabineDeoxycytidine

Autor:innen und Institutionen

  • Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Hospital Municipal da Vila Santa Catarina, São Paulo, Brazil.
  • Hospital Mario Penna, Belo Horizonte, Brazil.
  • Hospital do Servidor Público Estadual de São Paulo, São Paulo, Brazil.
  • Fundação Faculdade Regional de Medicina de São José do Rio Preto-CIP São José, São José do Rio Preto, Brazil.
  • Hospital Moinhos de Vento, Porto Alegre, Brazil.

ORCID-Profile: Elice Carneiro Batista, Diogo Diniz Gomes Bugano, Rodrigo Guimarães Corradi, Renato Panhoca, João Antonio Soler, Andréa Lopes Ponte de Souza, Bruna Motke, Henrique Alkalay Helber, Bruna Dos Santos Sampaio, Frederico Monfardini, Gustavo Prado Dos Santos, Mariane Pereira, Arie Carneiro, Luiz Vicente Rizzo, Fernando Cotait Maluf

Zitieren

APA

Castello Dias Carneiro, A. P., Batista, E. C., Gomes Bugano, D. D., Corradi, R. G., Panhoca, R., Soler, J. A., Carvalhal, E., Ponte de Souza, A. L., Motke, B., Helber, H. A., Sampaio, B. D. S., Monfardini, F., Lamas Assis, S. R., Rodrigues Sant'Anna, V. A., Prado Dos Santos, G., Lopes da Silva, M., Duarte, F. M., Pereira, M., Fagundes Moia, D. D., …, & Maluf, F. C. (2026). Treatment Patterns and Outcomes in Localized Urothelial Carcinoma in Middle-Income Countries: A Multicenter Real-World Study. JCO Global Oncology, 12(4). https://doi.org/10.1200/go-25-00324

Vancouver

Castello Dias Carneiro AP, Batista EC, Gomes Bugano DD, Corradi RG, Panhoca R, Soler JA, et al. Treatment Patterns and Outcomes in Localized Urothelial Carcinoma in Middle-Income Countries: A Multicenter Real-World Study. JCO Global Oncology. 2026;12(4). doi:10.1200/go-25-00324

BibTeX
@article{CastelloDiasCarneiro2026,
  author = {Castello Dias Carneiro, André Paternò and Batista, Elice Carneiro and Gomes Bugano, Diogo Diniz and Corradi, Rodrigo Guimarães and Panhoca, Renato and Soler, João Antonio and Carvalhal, Eduardo and Ponte de Souza, Andréa Lopes and Motke, Bruna and Helber, Henrique Alkalay and Sampaio, Bruna Dos Santos and Monfardini, Frederico and Lamas Assis, Silvia Regina and Rodrigues Sant'Anna, Viviane Aparecida and Prado Dos Santos, Gustavo and Lopes da Silva, Mayla and Duarte, Flávia Miranda and Pereira, Mariane and Fagundes Moia, Diogo Duarte and Soares, Ronaldo Vicente Pereira and Carneiro, Arie and Perini, Guilherme Fleury and Rizzo, Luiz Vicente and Maluf, Fernando Cotait},
  title = {Treatment Patterns and Outcomes in Localized Urothelial Carcinoma in Middle-Income Countries: A Multicenter Real-World Study},
  journal = {JCO Global Oncology},
  year = {2026},
  volume = {12},
  number = {4},
  doi = {10.1200/go-25-00324}
}
Kostenlos starten →